Pharma firms likely to post 11% growth in sales, EBITDA in Q1FY26: Report
However, the report added that the muted domestic demand in April and March may slightly offset gains.
The hospitals segment is projected to see robust 17 per cent year-on-year growth in both sales and EBITDA, supported by increased footfalls, new bed additions, and a modest rise in ARPOB.
In diagnostics, volume growth, better mix, and M&A activity are expected to contribute to a 14 per cent YoY sales increase across the coverage.
"For pharma companies, we expect continued traction across most markets to drive 11%/11% yoy growth in overall sales/EBITDA in 1QFY26," the report added.
India's pharmaceutical market for FY 2023-24 is valued at USD 50 billion with domestic consumption valued at USD 23.5 billion and export valued at USD 26.5 billion.
The domestic pharma industry is considered to be the world's third largest by volume and 14th in terms of value of production. With an extremely diversified product base covering generic drugs, bulk drugs, over-the-counter drugs, vaccines, biosimilars, and biologics, the Indian pharmaceutical industry has a strong presence at the global level.
According to National Accounts Statistics 2024, published by the Ministry of Statistics and Programme Implementation, total output for industry i.e. Pharmaceuticals, medicinal and botanical products is Rs. 4,56,246 crores for FY 2022-23 at constant prices, of which value added is ₹ 1,75,583 crores.
As per government data 9,25,811 number of persons are engaged in Pharmaceuticals, medicinal and botanical products industry during FY 2022-23.
Research & Development (R&D) and innovation in Pharma Sector is done by number of institutions and organizations under various scientific Ministries/Departments.
The Department of Pharmaceuticals has set up seven National Institutes of Pharmaceutical Education & Research (NIPERs) as institutes of national importance, which besides imparting postgraduate and doctorate education, conduct high end research in various pharma specializations.
Further, Department has framed a "National Policy on Research & Development and Innovation in Pharma-MedTech Sector in India" to encourage R&D in pharmaceuticals and medical devices.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
26 minutes ago
- Time of India
Currency watch: Rupee rises 16 paise to 85.76 against dollar; crude oil slide & weak greenback lift sentiment
The rupee appreciated by 16 paise to settle at 85.76 against the US dollar on Tuesday, helped by a weaker greenback and softer crude oil prices globally. However, persistent foreign fund outflows and uncertainty surrounding the ongoing India-US trade negotiations limited the currency's upward movement, according to forex dealers. At the interbank foreign exchange market, the rupee opened at 85.97 and moved in a tight range between 85.75 and 85.97 during the session. It eventually ended the day at 85.76, recovering from its previous close of 85.92, PTI reported. "The Reserve Bank of India has been guarding the rupee at the 86.00 level and on Tuesday also ensured that the rupee opens a tad higher than 86," said Anil Kumar Bhansali, Head of Treasury and Executive Director at Finrex Treasury Advisors LLP. He added, "For tomorrow (Wednesday), we expect the rupee to be in the range of 85.50–86.10 with expectations of more flows." Dollar, crude prices ease The dollar index, which tracks the US currency against a basket of six peers, declined 0.11% to 97.97, supporting emerging market currencies. Brent crude, the global oil benchmark, was down 0.43% to $68.91 per barrel in futures trade, reducing pressure on India's import bill. Trade talks and equity flows in focus The gains in the rupee were tempered by ongoing concerns over the outcome of bilateral trade negotiations between India and the US. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Đây có thể là thời điểm tốt nhất để giao dịch vàng trong 5 năm qua IC Markets Tìm hiểu thêm Undo A team from India's commerce ministry is currently in Washington for the latest round of discussions on the proposed bilateral trade agreement. The four-day meeting began on Monday and is set to conclude on Thursday. M eanwhile, India's merchandise exports held steady at $35.14 billion in June, while the trade deficit narrowed to a four-month low of $18.78 billion, according to government data released Tuesday. On the domestic equities front, both benchmark indices ended in the green. The Sensex rose 317.45 points to close at 82,570.91, and the Nifty advanced 113.50 points to settle at 25,195.80. Foreign institutional investors (FIIs) were net buyers on the day, purchasing equities worth Rs 120.47 crore, according to stock exchange data. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Time of India
26 minutes ago
- Time of India
When Rs 12 beats Rs 175: Bengaluru founder snubs costly auto prices, uses cheaper option to protest ‘stupid fares'
Swapnil Jain , co-founder of Ather Energy , did not expect a normal Monday morning commute to kick up such noise. He had both his vehicles parked at the office, so when he needed to get back, he tried the usual option. 'For various reasons, both my vehicles were parked at the office and I had no ride. Tried booking an auto because it is only 4 kms, but the price was ₹175. Heck with it, just decided to take a bus to office at ₹12,' he posted on X. And that was that. Or so he thought. 'Protesting stupid auto prices' Calling it what it was, Jain wrote, 'This is me protesting against the stupid auto prices.' — swapniljain89 (@swapniljain89) Live Events The phrase struck a chord. In Bengaluru, short auto rides turning costly is nothing new. Jain's public refusal felt relatable for many. His ₹12 bus ticket said more than a rant ever could. UPI payment, no loose change There was more to this than the fare. Jain pointed out that BMTC's UPI option makes life easier. No awkward wait for coins. No hunting for change in the pocket. He also gave a nod to Switch Mobility's electric buses . Comfortable enough, he said. A slight lag in acceleration did not bother him much. He figured it was down to shifting passenger weight. Bengaluru joins in The post caught on. Others began to chip in with their own stories. One user wrote, 'BMTC has been my primary mode for the last 1 year. Other than the sudden acceleration or braking, no complaints. No issue with frequency (500D), and no last-mile connectivity issues either.' Someone else shared, 'Use the Namma BMTC app for live tracking. It's not perfect, but it works. Pair it with UPI and you're sorted.' Another liked Jain's small stand, saying, 'I like how you don't waste money on simple things. It's not just about saving ₹100- ₹150, it's about staying grounded in the roots we come from.' Of course, not everyone clapped along. One user poked fun at Jain's scooters. 'Same way we don't want to waste money on your scooters that stop when there's a pillion rider. You call that derating? Hilarious!' the user said. Someone found fault with the buses too. 'Why can't the floor be flat? Too many steps inside, feels like climbing into an auditorium,' read another reply. Others dropped tips. 'You can get daily passes through the Tummoc app too. Also, airport buses on the BMTC app are really accurate.' Under it all, this was not only about a short bus ride. Jain's post pulled out an old complaint Bengaluru commuters share quietly every day. Auto fares that feel random. The relief when the bus turns up on time. Small fixes like paying through an app. 'Needed a rick in the rain, guess who's charging Rs 175 for 3 km? Rapido!' another user added, showing this is not one man's story. Swapnil Jain's choice to spend twelve rupees instead of one seventy-five will not overhaul Bengaluru's transport overnight. But it has pushed a simple idea back into the open. Sometimes a bus ride is worth more than it costs. And a small protest can make people pause and think before hailing the next pricey rick.
Time of India
31 minutes ago
- Time of India
ELI scheme set create jobs, enhance social security
Vadodara: The Employment-Linked Incentive (ELI) scheme, approved by the Cabinet under Prime Minister Narendra Modi , will boost employment generation, improve employability and extend social security coverage. Mitesh Rajmane, Regional PF Commissioner Grade 2, Vadodara, said on Tuesday. The ELI scheme has a total outlay of Rs 99,446 crore and aims to incentivize the creation of 3.5 crore jobs over two years. "The scheme, set to take off from Aug 1, will provide incentives to employees and employers to boost job creation. The benefits of the scheme will be applicable to jobs created between Aug 1, 2025, and July 31, 2027," Rajmane said, while addressing mediapersons. The Vadodara regional office of the Employees Provident Fund Organization (EPFO) has jurisdiction over five districts — Vadodara, Panchmahals, Dahod, Mahisagar and Chhota Udepur — and covers 23,500 establishments with 8,75,000 Universal Account Numbers (UANs) and 90,000 pensioners. "Under Part 1, first-time employees registered with EPFO will get one month's EPFO wage, that is up to Rs 15,000 in two instalments. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Struggling With Belly Fat? Try This at Home Home Fitness Hack Shop Now Undo The first instalment will be given on the completion of six months' employment and the second after a year, on successful completion of a financial literacy programme," he said. "Under Part 2 of the scheme, the govt will provide an incentive of up to Rs 3,000 per employee per month to employers for a duration of two years for appointing additional employees with a minimum of six months' continuous employment," he said.
